Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Renal Insufficiency × Data Collection × Plasma cell × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Sezary Syndrome 1 Renal Insufficiency 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Dexamethasone 13 Bortezomib 8 Cyclophosphamide 5 Lenalidomide 4 pomalidomide 3 isatuximab 3 Calcium Dobesilate 3 Thalidomide 2 Kidney Transplantation 2 melflufen 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 carfilzomib 1 belantamab mafodotin 1 auricularum 1 Whole-Body Irradiation 1 Tablets 1 Ranitidine 1 Plasmapheresis 1 L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1 Drug Therapy 1 Doxorubicin 1 Diphenhydramine 1 Data Collection 1 Cyclosporine 1 Bendamustine Hydrochloride 1 BHQ880 1 Azacitidine 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03234335 2023-05-06

IRMYG

Centre Hospitalier Universitaire de Saint Etienne

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡